Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFLAZACORT for Urticaria chronic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 21 adverse event reports in the FDA FAERS database where DEFLAZACORT was used for Urticaria chronic.

Most Reported Side Effects for DEFLAZACORT

Side Effect Reports % Deaths Hosp.
Weight increased 468 12.2% 1 22
Off label use 315 8.2% 9 42
Fall 206 5.4% 5 41
Vomiting 139 3.6% 0 20
Nasopharyngitis 134 3.5% 1 10
Abnormal behaviour 129 3.4% 0 8
Influenza 120 3.1% 2 16
Rash 114 3.0% 2 16
Headache 104 2.7% 1 8
Pyrexia 104 2.7% 4 23
Abdominal pain upper 103 2.7% 0 8
Product dose omission 99 2.6% 0 14
Weight decreased 98 2.6% 0 10
Anger 97 2.5% 0 4
Increased appetite 95 2.5% 0 5

Other Indications for DEFLAZACORT

Muscular dystrophy (1,542) Duchenne muscular dystrophy (1,446) Product used for unknown indication (508) Becker's muscular dystrophy (186) Asthma (33) Rheumatoid arthritis (29) Immunosuppressant drug therapy (20) Muscle disorder (14) Juvenile idiopathic arthritis (12) Pulmonary sarcoidosis (12)

Other Drugs Used for Urticaria chronic

OMALIZUMAB (1,064) CETIRIZINE (158) MONTELUKAST (134) CYCLOSPORINE (93) FEXOFENADINE (64) DOXEPIN (61) HYDROXYZINE (49) DUPILUMAB (46) LEVOCETIRIZINE (43) RANITIDINE (43)

Related Pages

DEFLAZACORT Full Profile All Urticaria chronic Drugs DEFLAZACORT Demographics DEFLAZACORT Timeline